INTRAVASCULAR COAGULATION AND FIBRINOLYSIS BY STAPHYLOCOAGULASE. COMPARISON WITH THROMBIN.
Explore the source record for details and available documents.
Antithrombin III↗
Biomedical subjects
S NIEWIAROWSKI
Publications and source records attributed to S NIEWIAROWSKI.
METHOD FOR DETERMINING ANTIHEPARIN ACTIVITY OF PLATELETS AND ERYTHROCYTES.
Explore the source record for details and available documents.
Animals↗
FIBRINOLYTIC ACTIVITY OF TISSUE SECTIONS OF THE DOG KIDNEY.
Explore the source record for details and available documents.
Deoxyribonuclease I↗
[AN EPSILON-AMINOCAPROIC ACID PREPARATION AND ITS USE IN THE TREATMENT OF HEMORRHAGE AND HEMORRHAGIC DIATHESIS].
Explore the source record for details and available documents.
Aminocaproates↗
FIBRINOLYSIS AND FIBRINOGEN BREAKDOWN PRODUCTS (ANTITHROMBIN VI) IN RENAL VENOUS BLOOD (RVB) IN DOG.
Explore the source record for details and available documents.
Blood Coagulation↗
METHOD FOR DETERMINING EPSILON-AMINOCAPROIC ACID (EACA) IN BLOOD PLASMA, BASED ON THE ANTIFIBRINOLYTIC PROPERTIES OF THIS COMPOUND.
Explore the source record for details and available documents.
Aminocaproates↗
[INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. I. SPECIFIC INHIBITORS OF FIBRINOLYSIS].
Explore the source record for details and available documents.
Aminocaproates↗
[INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. II. INHIBITORS OF PROTEOLYSIS AND FIBRINOLYSIS].
Explore the source record for details and available documents.
Enzyme Inhibitors↗
MACROTHROMBOCYTIC THROMBOPATHIA. CLINICAL, COAGULATION AND HEREDITARY ASPECTS.
Explore the source record for details and available documents.
Blood Coagulation↗
Influence of plasmin on the clotting and anticlearing activities of platelets.
Explore the source record for details and available documents.
Blood Coagulation↗
[CONGENITAL AFIBRINOGENEMIA ACCORDING TO OUR OBSERVATIONS].
Explore the source record for details and available documents.
Afibrinogenemia↗
Arginine esterase activity of the contact (Hageman) factor.
Explore the source record for details and available documents.
Arginine↗
Coagulation disorders in thrombocythaemia, a study of seven cases.
Explore the source record for details and available documents.
Blood Coagulation Disorders↗
Blood clotting factors in cerebrospinal fluid.
The activity of blood clotting factors has been investigated in cerebrospinal fluid. No cephalin-like activity was found in cerebrospinal fluid but prothrombin activity averaged about 0.5% of normal plasma activity. The activity of factor VII was negligible in almost all cases. The activity of antihaemophilic factors showed great variation but in the majority of cases it did not exceed 1% of normal plasma activity. High activity for factor V was found in almost all samples of cerebrospinal fluid.
Blood Coagulation↗
[Congenital afibrinogenemia. Biological study of 2 cases].
Explore the source record for details and available documents.
Afibrinogenemia↗
[Dr. Maksymilian ROSENMANN (1889-1960); in memoriam].
Explore the source record for details and available documents.
History↗
[Studies on the mechanism of heparin action on blood clotting and fibrinolysis].
Explore the source record for details and available documents.
Blood Coagulation↗
The antithrombin activity of glucuronic esters of bilirubin.
The plasma of patients with pronounced jaundice as well as that of cats with experimental obstructive jaundice inhibits the clotting of normal plasma with thrombin. The influence of different bile constituents-bilirubin, bilirubin glucuronides, sodium salts of bile acid-on the clotting of plasma or fibrinogen with thrombin was examined. Bilirubin glucuronides in concentrations above 8 mg.% showed antithrombic activity but other substances were inactive. Glucuronic acid and phenolphthalein glucuronide in concentrations up to 100 mg.% did not have any influence on the thrombin time.
Animals↗